Is pharmacotherapy guideline concordance consistent across patients who received pragmatic treatment for major depressive disorder?

Document Type

Article

Publication Date

9-1-2026

Publication Title

Int J Psychiatry Clin Pract

Keywords

Humans, Female, Major Depressive Disorder, Male, Guideline Adherence, Adult, Antidepressive Agents, Middle Aged, Practice Guidelines as Topic, Sex Factors, United States, Algorithms, Comorbidity

Abstract

OBJECTIVE: Pharmacotherapy guideline concordance for the treatment of major depressive disorder (MDD) is associated with improved symptom severity, but it is unclear whether such associations vary by patients’ characteristics or their comorbidity burden. We sought to determine whether guideline concordance varied significantly by 1) sociodemographic characteristics or 2) comorbidity. METHODS: This study evaluated 1,403 U.S. adults (67% female, 85% non-Hispanic/Latino White, mean age of 43 years) with non-psychotic MDD and complete data (n = 1,241/1,403). We used a guideline concordance algorithm (GCA-8) to measure pharmacotherapeutic concordance with the Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines and multivariable general linear and proportional odds models to examine associations between this GCA-8 score and patients’ characteristics. RESULTS: Being male was significantly associated with higher guideline concordance, but guideline concordance did not vary significantly by any other sociodemographic characteristics. Similarly, no comorbidities examined by this study presented substantial evidence of associations with guideline concordance. Within this sample, the GCA-8 algorithm consistently measured the degree of guideline concordance across different patient types. CONCLUSIONS: This study suggests that guideline concordance for MDD pharmacotherapy, as measured by the GCA-8, does not significantly vary by the comorbidities or sociodemographic characteristics analysed in this study, except for patient-reported gender. Looking at 1 year of pharmacotherapy for major depressive disorder, the degree of alignment with clinical guidelines did not vary significantly by most sociodemographic characteristics or comorbidities in a U.S. specialty care cohort. On average, men in this study sample received treatment that was significantly more aligned with clinical guidelines. There may be difficult-to-detect heterogeneity in the degree of pharmacotherapy guideline concordance for major depressive disorder across race, ethnicity and sex in similar patient populations.

Medical Subject Headings

Humans; Female; Major Depressive Disorder; Male; Guideline Adherence; Adult; Antidepressive Agents; Middle Aged; Practice Guidelines as Topic; Sex Factors; United States; Algorithms; Comorbidity

PubMed ID

42070122

Volume

30

Issue

3

First Page

271

Last Page

279

Find It @ Sladen

Share

COinS